My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Target Posts Q3 Earnings Miss: Analysts Slash...
Natural Gas Prices Spike To Over 1-Year Highs...
Nvidia Delivered 'Jaw Dropping' Q3 Earnings,...
International Criminal Court Issues Arrest Wa...
Reddit Recovers from Major Service Outage On...
Uber Could Pick Up $10M Stake In Chinese Auto...
Tesla Registrations Drop By Over 20% In Octob...
Delta Chief Says Trump Could Be A 'Breath Of...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    VANECK ETF TR PHARMACEUTICAL ETF (NASDAQ: PPH)

    Overview
    current price
    $87.94
    $87.94
    change
    0.50 | 0.57%
    0.50 | 0.57%
    Yesterday's Close
    87.44
    open
    87.46
    volume
    0.10 M
    30d. avg volume.
    0.24 M
    1 day
    87.00 - 88.05
    52 weeks
    77.60 - 99.51
    p/e
    0.00
    beta
    0.6543
    market cap
    0.60 B
    dividend yield
    1.84%
    Industry
    -
    PPH by TradingView
    News and Commentary
    Pharmaceutical Stocks to Outperform in 2023 As the calendar turns to a new year, investors face a challenging set of circumstances. Inflation is trending lower but well above what is comfortable for the Federal Reserve or...
    Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...
    Pfizer Q2 Earnings Boost Pharmaceutical ETFs After Raising Vaccine Revenue Forecasts Pfizer (PFE 
    ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...
    ETF Weekly: Funds That are Affected by the Coronavirus Global markets have been impacted this week due to the outbreak of a coronavirus in China ahead of the Lunar New Year. Currently, the World Health Organization is setting out to...
    StockTwits
    StockTwits
    Most Shared
    SolarEdge Q3 Results Miss Expectations; Analysts Warn Of Cash Flow Challenges And Need For Cost Cuts
    US Economy Grows Less Than Expected In Q3, Yet Private Employment Soars By 233,000 In October
    Netflix Crash Hits Jake Paul-Mike Tyson Fight: Can Streaming Platform Handle Christmas Day NFL Action?
    Most Popular
    Meta, Amazon, Microsoft Partner On Defense AI Initiative
    Ford CEO Jim Farley Says He Tries To Drive All Vehicles From Competition After Expressing Adoration For Xiaomi SU7: 'Try Me,' Says Tesla Cybertruck
    Palantir Overtakes Lockheed Martin In Market Cap, How Does The 'Messi Of AI' Stack Up Against The Traditional Defense Player
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Covid19
    Google
    Tesla
    mobile iOS Android
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?